-+ 0.00%
-+ 0.00%
-+ 0.00%

Haemonetics Sees Revenue for 2026 FY is expected to down by -3 to -1% YoY

Benzinga·02/05/2026 12:25:39
Listen to the news

Haemonetics (NYSE:HAE) sees Revenue for 2026 FY is expected to down by -3 to -1% YoY